摘要
目的 构建表达幽门螺杆菌 (Hp)尿素酶A亚单位 (UreA)和过氧化氢酶 (KatA)的减毒鼠伤寒沙门氏菌疫苗株 ,对研制抗Hp感染重组疫苗的可行性进行探讨。方法 PCR方法从Hp基因组中扩增出ureA和katA片段 ,将其插入pGSTag表达载体中 ,重组质粒再转入减毒鼠伤寒沙门氏菌。结果 对重组质粒进行限制酶切分析和PCR检测 ,证实两种基因已被克隆入pGSTag ,并转入减毒鼠伤寒沙门氏菌。结论 本研究成功地将表达HpureA和katA融合基因的重组质粒转入减毒鼠伤寒沙门氏菌中 ,构建了UreA/KatA双价口服活疫苗 。
Aim\ To construct the recombinant attenuated Salmonella typhimurium vaccine strain expressing urease A subunit(UreA) and catalase(KatA) of Helicobacter pylori (Hp), and investigate the feasibility of developing a recombinant vaccine against Hp infection.Methods\ ureA and katA were amplified by PCR from Hp genome and cloned into expression vector pGSTag.This recombinant plasmid was transformed into attenuated Salmonella typhimurium. Results \ With restriction enzyme digestion and PCR,it was showed that ureA and katA have been inserted into pGSTag and introduced into the attenuated Salmonella typhimurium.Conclusion\ We were successful in transforming the recombinant plasmid expressing the ureA and katA fusion genes into attenuated Salmonella typhimurium and constructing a ureA / katA bivalent live oral vaccine strain . Our study laid foundation of further studying the effect of this vaccine on prevention and treatment of Hp infection.
出处
《中国人兽共患病杂志》
CSCD
北大核心
2000年第5期66-68,共3页
Chinese Journal of Zoonoses
基金
卫生部临床学科重点项目!No 97040226
广东省科技计划重点攻关项目!NO.99NO4802G
广东省自然科学基金课题!NO.990077